Elanco Animal Health INC Form 4 insider transactions

Rajeev A. Modi, Elanco Animal Health's Executive Vice President, acquired 73.6781 deferred stock units, increasing his beneficial ownership to 6,964.7245 units.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 150.2572 deferred stock units, increasing his beneficial ownership.

Elanco Animal Health Inc's Executive Vice President, Rajeev A. Modi, acquired 76.7564 deferred stock units at a price of $18.43 per unit.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 154.6198 deferred stock units, increasing his beneficial ownership.

Rajeev A. Modi, Elanco's EVP, acquired 78.9849 deferred stock units, increasing his beneficial ownership to 6,814.29 units.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 166.1212 deferred stock units at a price of $16.67 per unit.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 84.8602 deferred stock units, aligning executive incentives with company performance.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 185.6059 deferred stock units, increasing his beneficial ownership to 17,220.9125 units.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 94.8137 deferred stock units, increasing his beneficial ownership to 6,650.4449 units.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 94.9409 deferred stock units, increasing his beneficial ownership to 6,555.6312 units.

Elanco Animal Health Inc.'s President, CEO, and Director, Jeffrey N. Simmons, has filed a Form 4 indicating a future acquisition of 185.855 deferred stock units on July 11, 2025, under a pre-arranged plan.

Elanco Animal Health Inc.'s Chief Accounting Officer, James M. Meer, disposed of 1,161 shares of common stock on July 3, 2025, to cover tax obligations related to vested restricted stock units.

Elanco Animal Health Inc.'s EVP, Manufacturing and Quality, Grace McArdle, reported a planned disposition of 4,346 common shares on July 3, 2025, to cover tax liabilities from restricted stock unit vesting.

Elanco Animal Health Inc. director Kapila K. Anand acquired 603.9916 deferred stock units by electing to defer cash retainer fees, increasing her total beneficial ownership to 8,085.358 units.

Elanco Animal Health Inc. executive Rajeev A. Modi acquired 98.9937 deferred stock units, increasing his beneficial ownership to 6,460.6903 units.

Elanco Animal Health Inc.'s President, CEO, and Director, Jeffrey N. Simmons, is scheduled to acquire 193.7887 deferred stock units on June 27, 2025, increasing his beneficial ownership to 16,849.4516 units.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health Inc., acquired 102.4345 deferred stock units, increasing his direct beneficial ownership in the company.

Elanco Animal Health Inc.'s President, CEO, and Director, Jeffrey N. Simmons, has acquired 200.5243 deferred stock units, increasing his beneficial ownership.

Elanco Animal Health Inc.'s President, CEO, and Director, Jeffrey N. Simmons, acquired 206.0446 deferred stock units on May 30, 2025, increasing his direct beneficial ownership.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health Inc., acquired 105.2545 deferred stock units on May 30, 2025, increasing his beneficial ownership.

Elanco Animal Health's CEO, Jeffrey Simmons, reports the acquisition of deferred stock units convertible to common stock.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units representing the right to receive common stock or cash equivalent.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Elanco Animal Health CEO Jeffrey N. Simmons acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Jeffrey N. Simmons, CEO of Elanco Animal Health, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, acquired deferred stock units convertible to common stock, as reported in a recent SEC filing.

Jeffrey N. Simmons, CEO of Elanco Animal Health, reports acquisition of deferred stock units.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units convertible to common stock.

Timothy Bettington, an executive at Elanco Animal Health, reported disposing of 23,558 shares of common stock to cover tax obligations.

Director Kapila K. Anand reports acquisition of deferred stock units in Elanco Animal Health Inc. through a director deferral plan.